Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Nova Eye Medical (ELXMF) Stock Price & Analysis

9 Followers

ELXMF Stock Chart & Stats

$0.01$0.00(0.00%)
At close: 4:00 PM EST
$0$0.1$0.2$0.3Sep 29Apr 1Oct 12Apr 4Apr 25Apr 15
Day’s Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.25
Previous Close
$0.01
Volume
N/A
Average Volume (3M)
0
Market Cap
$29.90M
Enterprise Value
$31.34M
Total Cash (Recent Filing)
$964.00K
Total Debt (Recent Filing)
$2.39M
Price to Earnings (P/E)
―
Beta
7.50
Next Earnings
Mar 02, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Jul 21, 2020
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

The substantial multi-year increase in revenue indicates that Nova Eye Medical has expanded its commercial scale and market activity. Continued top-line progress can support operating leverage, strengthen its position with ophthalmic customers, and provide a foundation for future profitability if growth persists.

Gross Margin Improvement

Higher gross margins improve the economic value of each sale and create greater potential to absorb operating expenses as revenue grows. Combined with narrowing losses, this suggests the underlying business model is becoming more efficient and could support a more durable path toward breakeven.

Conservative Leverage

Low leverage limits interest and refinancing pressure, giving the company more flexibility while it develops and commercializes ophthalmic devices. A relatively conservative debt position also reduces the risk that lenders constrain strategic investment during the transition toward sustainable profitability.

Bears Say

Ongoing Unprofitability

Although losses have narrowed materially, Nova Eye Medical has not yet demonstrated consistent profitability. Continued negative margins limit internally generated funding, leave results sensitive to execution and scale, and make the company dependent on further improvement before earnings can become a durable strength.

Persistent Cash Burn

Repeated negative operating and free cash flow show that accounting improvement has not yet translated into self-funding operations. Ongoing cash consumption can require additional financing or cost controls, potentially slowing product investment and reducing flexibility until cash generation turns positive.

Shrinking Equity Base

The reduction in shareholders’ equity indicates that accumulated losses have eroded the company’s capital base despite low debt. If this trend continues, financial resilience may weaken, external funding could become more important, and less capital would be available to support long-term commercial expansion.

Nova Eye Medical News

ELXMF FAQ

What was Nova Eye Medical’s price range in the past 12 months?
Nova Eye Medical lowest stock price was $0.01 and its highest was $0.25 in the past 12 months.
What is Nova Eye Medical’s market cap?
Nova Eye Medical’s market cap is $29.90M.
When is Nova Eye Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nova Eye Medical’s earnings last quarter?
Nova Eye Medical released its earnings results on Aug 26, 2026. The company reported -$0.002 earnings per share for the quarter.
Is Nova Eye Medical overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Nova Eye Medical pay dividends?
Nova Eye Medical pays a dividend of $0.294 which represents an annual dividend yield of ―. See more information on Nova Eye Medical dividends here
What is Nova Eye Medical’s EPS estimate?
Nova Eye Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nova Eye Medical have?
Nova Eye Medical has 284,921,080 shares outstanding.
What happened to Nova Eye Medical’s price movement after its last earnings report?
Nova Eye Medical reported an EPS of -$0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nova Eye Medical?
Currently, no hedge funds are holding shares in ELXMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology